Population Pharmacokinetics of Intravenous and Intramuscular Streptomycin in Patients with Tuberculosis

@article{Zhu2001PopulationPO,
  title={Population Pharmacokinetics of Intravenous and Intramuscular Streptomycin in Patients with Tuberculosis},
  author={Min Zhu and William J. Burman and George S. Jaresko and Shaun E. Berning and Roger W. Jelliffe and Charles A Peloquin},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2001},
  volume={21}
}
  • Min Zhu, W. Burman, +3 authors C. Peloquin
  • Published 1 September 2001
  • Medicine
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Study Objectives. To determine population pharmacokinetic parameters of streptomycin after administration of multiple intramuscular and intravenous doses. 
An Alternative Approach to Tuberculosis Management with Intravenous Streptomycin
TLDR
Intravenous administration of streptomycin may be a useful route of administration without undesirable toxicities in patients with advanced tuberculosis. Expand
Chapter 17: Pharmacological Considerations of Antitubercular Agents in Children
This review is intended to provide a comprehensive summary of the existing paediatric clinical pharmacology data on the drugs and drug classes that are used for, or proposed for use in, the treatment
Pharmacology of Mycobacterial Drugs in Children
TLDR
In this review, the pharmacokinetics (PK) of antitubercular drugs will be reviewed in the context of the pediatric population and future considerations to enhance the understanding of TB drugs used in children will be explored. Expand
Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan.
  • Wen-Yueh Hung, M-C Yu, +5 authors K. Bai
  • Medicine
  • The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2014
TLDR
Lower than recommended serum CS concentrations and delayed absorption were common and it is essential to develop practical TDM to maintain proper serum drug concentrations. Expand
Initial combination of injectable and oral anti-tuberculosis agents for the treatment of severe disseminated tuberculosis
TLDR
An HIV-infected patient presenting with severe disseminated tuberculosis with extensive intestinal involvement was successfully treated with an initial combination regimen of injectable and oral anti-tuberculosis agents. Expand
Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children
TLDR
Children routinely receiving levofloxacin for MDR-TB prophylaxis or disease in Cape Town, South Africa, underwent pharmacokinetic sampling following receipt of a dose of 15 or 20 mg/kg of body weight given as a whole or crushed tablet(s) orally or via a nasogastric tube, finding exposures considerably lower than those in adults. Expand
Tuberculosis: introduction, drug regimens, and multidrug-resistance
TLDR
The new antimycobacterial agents are acquired from various types of medications, function across a number of mechanism of action, and are at different level of development. Expand
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
TLDR
The reduced activity of streptomycin during the second phase of monotherapy is not associated with the selection of strePTomycin-resistant mutants but, rather, with the presence of phenotypically tolerant 'persisters'. Expand
Population Pharmacokinetic Models of Anti-Tuberculosis Drugs in Patients: a Systematic Critical Review.
TLDR
More and better models, ideally using nonparametric approaches linked with clear pharmacodynamic goals, are required to optimize anti-TB drug dosing, as recommended in the WHO End TB strategy. Expand
Intravenous Streptomycin for Treatment of Mycobacterium tuberculosis Meningitis in an Infant
TLDR
The safe and effective use of intravenous strePTomycin in this infant suggests that this route of administration may be an alternative to intramuscular streptomycin. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Streptomycin pharmacokinetics in malnutrition.
Pharmacokinetic parameters of streptomycin such as plasma concentration, plasma half-life, urinary excretion, and in vitro and in vivo binding to plasma proteins were studied in undernourished andExpand
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
TLDR
The results have shown that the pattern of absorption and metabolism found after administration of each drug alone did not differ from that found afterAdministration of the drugs in free and fixed combination. Expand
[Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
TLDR
The study on the pharmacokinetics of streptomycin and isoniazid in resected lung tissue and blood specimens from patients with respiratory tuberculosis treated with ultrasound inhalations showed that their concentrations in the lungs were high and persisted at the minimum bacteriostatic level for 48 hours. Expand
Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis
TLDR
Comparison of the drug levels in the lung tissue with those in the blood revealed correlation between the characteristics, which may be used for correction of the therapy with streptomycin and isoniazid ultrasound inhalations, especially when Mycobacterium tuberculosis are resistant to the drugs. Expand
Pharmacokinetic aspects of streptomycin treatment of neonatal septicemia.
TLDR
It is suggested that the guiding principle to avoid plasma levels above 25 microliter/ml is reasonable and that an otological examination of the newborns was performed within 13 months after streptomycin treatment and no signs of hearing defects were noted. Expand
Using therapeutic drug monitoring to dose the antimycobacterial drugs.
TLDR
TDM with the antimycobacterial drugs offers the clinician a chance to ensure that the patient achieves serum concentrations above the MIC of the pathogen, and it is hoped that these efforts will provide insight into the nature of current therapeutic problems. Expand
The pharmacodynamics of aminoglycosides.
Recently, a more complete understanding of the pharmacodynamics of aminoglycosides has been recognized, indicating that this class of antibiotics exhibits both concentration-dependent bactericidalExpand
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
TLDR
Treatment of Tuberculosis should be individualized and based on susceptibility studies, except for children who have miliary tuberculosis, bone/joint tuberculosis, or tuberculous meningitis who should receive a minimum of 12 mo of therapy. Expand
Short-term intermittent chemotherapy of experimental tuberculosis in the guinea pig
Summary Guinea pigs with moderately severe experimental tuberculosis were treated for six weeks with thiacetazone, ethionamide or streptomycin, and the progress of the disease was assessed by scoringExpand
Single or multiple daily doses of aminoglycosides: a meta- analysis
TLDR
Once daily administration of aminoglycosides in patients without pre-existing renal impairment is as effective as multiple daily dosing, has a lower risk of nephrotoxicity, and no greater risk of ototoxicity. Expand
...
1
2
3
...